First national consensus on diabetic macular edema

Abstract

Diabetic macular edema (DME) represents the leading cause of vision loss in patients with diabetes mellitus. It is a complex disease that demands extensive experience from ophthalmologists and retinologists to achieve a timely detection, an accurate diagnosis and adequate treatment. At present, there are various and innovative treatment alternatives that must be evaluated along with the characteristics and needs of each patient to provide the greatest benefits.This document describes the characteristics and scientific evidence that support some of these treatments, as well as the Consensus Group’s proposal for the most appropriate treatment of patients with DME according to their characteristics and profiles.